| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $354,540,091 ) (Continued on the next page) |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL164775 | Associations among maternal lifetime psychosocial stress, prenatal systemic and placental oxidative stress mixtures, and child asthma | 000 | 3 | NIH | 3/5/2025 | $629,881 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI185869 | Novel antiviral agents targeting early stage CMV replication | 000 | 1 | NIH | 8/11/2025 | $696,985 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21NS145550 | Mechano-Electrical Regulation of Neurogenesis | 000 | 1 | NIH | 7/31/2025 | $491,163 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES028927 | Longitudinal study of metal mixtures and the developmental origins of adolescent risk-taking | 002 | 7 | NIH | 8/12/2025 | $64,681 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES028927 | Longitudinal study of metal mixtures and the developmental origins of adolescent risk-taking | 003 | 7 | NIH | 8/13/2025 | $149,339 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES028927 | Longitudinal study of metal mixtures and the developmental origins of adolescent risk-taking | 001 | 7 | NIH | 8/8/2025 | $492,567 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL178943 | Development of a versatile paired prime editing toolkit for CFTR gene correction | 000 | 1 | NIH | 8/12/2025 | $730,268 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K76AG095108 | Opportunistic use of existing chest CT data for frailty screening | 000 | 1 | NIH | 8/11/2025 | $242,846 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 001 | 2 | NIH | 5/21/2025 | $33,799 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 2 | NIH | 3/4/2025 | $304,201 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99AI193231 | Mapping inflammatory bowel disease variants to genes and functional phenotypes in human macrophages | 000 | 1 | NIH | 8/5/2025 | $132,677 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA301237 | Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia | 000 | 1 | NIH | 8/7/2025 | $464,577 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA276087 | Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation | 002 | 4 | NIH | 7/1/2025 | $529,039 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 001 | 2 | NIH | 5/22/2025 | $56,919 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 000 | 2 | NIH | 2/12/2025 | $512,262 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA061256 | Pediatric Emergency Department-initiated Support program To Link Care (PEDS-TLC) for youth with substance use | 001 | 1 | NIH | 7/25/2025 | $0 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA061256 | Pediatric Emergency Department-initiated Support program To Link Care (PEDS-TLC) for youth with substance use | 000 | 1 | NIH | 7/11/2025 | $194,111 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY027301 | Characterization of vascular responses to intravitreal anti-VEGF injections in diabetic retinopathy | 002 | 7 | NIH | 7/10/2025 | $697,579 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | DP2AI192719 | Engineering Metal Ion-Immunity Crosstalk for Metalloimmunotherapy | 000 | 1 | NIH | 8/7/2025 | $507,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS134301 | Theta Phase-Locked Stimulation of Entorhinal-Hippocampal Inputs in Healthy and Epileptic Mice | 000 | 2 | NIH | 3/14/2025 | $47,374 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS144801 | Computational Mapping of Cerebral Metabolism During Development | 000 | 1 | NIH | 7/30/2025 | $629,796 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R61AG094602 | AAV-mediated Interrogation of the Brain FSH Receptor | 000 | 1 | NIH | 7/30/2025 | $2,129,396 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30CA265288 | Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach | 001 | 4 | NIH | 8/15/2025 | $54,538 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM160031 | Investigating the Mechanisms of Brain-Heart Communication Under Stress | 000 | 1 | NIH | 8/14/2025 | $420,834 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 7 | NIH | 3/5/2025 | $577,304 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY036095 | Epigenetic regulation of the Meibomian gland in homeostasis and aging | 000 | 1 | NIH | 8/15/2025 | $744,432 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA290438 | Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men | 000 | 1 | NIH | 3/12/2025 | $717,667 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY037134 | Nicotinic modulation of deep layer somatostatin interneurons for visual critical period plasticity | 000 | 1 | NIH | 3/13/2025 | $562,660 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 001 | 3 | NIH | 6/23/2025 | $1,284 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01CA304486 | Early Integrated Primary and Specialty Palliative Care for Glioblastoma. | 000 | 1 | NIH | 8/6/2025 | $194,940 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 000 | 3 | NIH | 3/12/2025 | $79,756 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 002 | 7 | NIH | 6/11/2025 | $64,146 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS128961 | Clinical & biological signatures of post-traumatic neurodegeneration: Leveraging the TBI Model Systems of Care to accelerate in vivo diagnosis of the late effects of TBI (LETBI) | 000 | 2 | NIH | 8/7/2025 | $1,638,533 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 001 | 2 | NIH | 6/12/2025 | $61,861 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA251754 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | 000 | 5 | NIH | 3/17/2025 | $626,369 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA049547 | Atherosclerosis in cocaine addiction: imaging risk with PET/MR | 000 | 4 | NIH | 3/17/2025 | $676,860 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 2 | NIH | 2/20/2025 | $556,760 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG1HL138645 | BMT CTN Core - Mount Sinai Consortium | 002 | 9 | NIH | 8/6/2025 | $219,211 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG071870 | Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females | 001 | 5 | NIH | 6/17/2025 | $55,401 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG071870 | Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females | 000 | 5 | NIH | 3/6/2025 | $623,274 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA251754 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | 001 | 5 | NIH | 5/23/2025 | $69,595 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA049547 | Atherosclerosis in cocaine addiction: imaging risk with PET/MR | 001 | 4 | NIH | 4/11/2025 | $75,205 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035804 | The PFAS exposure burden calculator: A novel tool for cross-study harmonization, biomonitoring and report-back | 000 | 1 | NIH | 7/23/2025 | $390,337 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 001 | 5 | NIH | 4/8/2025 | $164,155 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB036536 | Advancing Multiple Myeloma Prognostication and Monitoring through AI-Powered Comprehensive Imaging | 000 | 1 | NIH | 7/28/2025 | $755,336 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03CA300825 | Epigenetic Regulation of Melanoma-Associated Fibroblast Plasticity | 000 | 1 | NIH | 7/30/2025 | $169,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 000 | 5 | NIH | 2/26/2025 | $1,477,403 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI188112 | The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation | 000 | 1 | NIH | 7/23/2025 | $464,750 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI188112 | The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation | 001 | 1 | NIH | 8/7/2025 | $0 |
|
